Healthcare analysts Tulip Lim and Ji Liu drop in on the S&P Pharma Guy, Arthur Wong, to talk how HHS’s proposal to ban rebating from the Medicare market. What’s the impact on the ratings of the pharma supply chain players?

Healthcare analysts Tulip Lim and Ji Liu drop in on the S&amp;P Pharma Guy, Arthur Wong, to talk how HHS’s proposal to ban rebating from the Medicare market. What’s the impact on the ratings of the pharma supply chain players?

S&P Pharma Dose - Episode 30: Rebates And Pharma Supply Chain

S&P Global Ratings Podcast. Tune in for S&P Global Ratings analysts' opinions on trends and events that affect the global markets and your investment decisions. Download the S&P Global Ratings' Podcast to any portable audio device or your desktop. Make the most of your time and stay on top of important business developments around the world. Listen in! Our CreditMatters videos and podcasts provide an easy and informative way to keep up with S&P Global Ratings' global perspective on important credit market developments anytime, anywhere.

Business

S&amp;P Global Ratings Podcast. Tune in for S&amp;P Global Ratings analysts' opinions on trends and events that affect the global markets and your investment decisions. Download the S&amp;P Global Ratings' Podcast to any portable audio device or your desktop. Make the most of your time and stay on top of important business developments around the world. Listen in! Our CreditMatters videos and podcasts provide an easy and informative way to keep up with S&amp;P Global Ratings' global perspective on important credit market developments anytime, anywhere.

Share S&P Pharma Dose - Episode 30: Rebates And Pharma Supply Chain

Sign up to save your podcasts

S&P Pharma Dose - Episode 30: Rebates And Pharma Supply Chain

S&P Pharma Dose - Episode 30: Rebates And Pharma Supply Chain